ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

STP Spdr Msci Europe Materials Ucits Etf

306.70
-3.45 (-1.11%)
14 Jun 2024 - Closed
Delayed by 15 minutes
Name Symbol Market Type
Spdr Msci Europe Materials Ucits Etf EU:STP Euronext Exchange Traded Fund
  Price Change % Change Price Bid Price Offer Price High Price Low Price Open Price Traded Last Trade
  -3.45 -1.11% 306.70 306.40 307.00 310.65 306.10 310.65 256 16:35:24

American Stock Exchange to Trade Options on Eight Securities

03/02/2006 11:35pm

PR Newswire (US)


Spdr Msci Europe Materia... (EU:STP)
Historical Stock Chart


From Jun 2019 to Jun 2024

Click Here for more Spdr Msci Europe Materia... Charts.
NEW YORK, Feb. 3 /PRNewswire/ -- The American Stock Exchange(R) (Amex) will launch trading in options on Monday, February 6, 2006 on the following Nasdaq Stock Market and New York Stock Exchange listed stocks of: * AVI BioPharma, Inc. (Option Symbol: QVI/Stock Symbol: AVII) * Brigham Exploration Company (Option Symbol: QBJ/Stock Symbol: BEXP) * H.B. Fuller Company (Symbol: QVI) * Korn/Ferry International (Symbol: KFY) * The Men's Wearhouse, Inc. (Symbol: MW) * New River Pharmaceuticals Inc. (Option Symbol: QNC/Stock Symbol: NRPH) * Suntech Power Holdings Co., Ltd. (Symbol: STP) * Theravance, Inc. (Option Symbol: TQM/Stock Symbol: THRX) AVI BioPharma, Inc. options will open with position limits of 25,000,000 shares. The options will trade on the March expiration cycle. The specialist will be Jane Street Specialist LLC. AVI BioPharma, Inc. is a biopharmaceutical company that develops and commercializes products principally based on third-generation NEUGENE antisense technology. Brigham Exploration Company options will open with position limits of 7,500,000 shares. The options will trade on the February expiration cycle. The specialist will be Kellogg Capital Group, LLC. Brigham Exploration Company manufactures and markets adhesives, sealants, coatings, paints, and other specialty chemical products worldwide. H.B. Fuller Company options will open with position limits of 5,000,000 shares. Trinity Derivatives Group, LLC. H.B. Fuller Company an independent exploration and production company applies 3-D seismic imaging and other technologies to explore and develop onshore domestic natural gas and oil resources. Korn/Ferry International options will open with position limits of 7,500,000 shares. The options will trade on the March expiration cycle. The specialist will be Trinity Derivatives Group, LLC. Korn/Ferry International is an executive search firm with consultants based in offices across various countries. The Men's Wearhouse, Inc. options will open with position limits of 20,000,000 shares. The options will trade on the February expiration cycle. The specialist will be AGS Specialist, LLC. The Men's Wearhouse, Inc. retails men's attire. The company sells suits, sportswear, furnishings, and accessories. New River Pharmaceuticals Inc. options will open with position limits of 5,000,000 shares. The options will trade on the March expiration cycle. The specialist will be Susquehanna Investment Group. New River Pharmaceuticals Inc. is a specialty pharmaceutical company focused on developing safer and improved version of widely-prescribed drugs in the large and growing markets. Suntech Power Holdings Co., Ltd. options will open with position limits of 7,500,000 shares. The options will trade on the March expiration cycle. The specialist will be AGS Specialists, LLC. Suntech Power Holdings Co., Ltd. designs, develops, manufactures and market a variety of photovoltaic (PV) cells and modules. Theravance, Inc. options will open with position limits of 5,000,000 shares. The options will trade on the March expiration cycle. The specialist will be Group One Trading LP. Theravance, Inc. is a biopharmaceutical company that discovers, develops, and markets small molecule medicines for unmet medical needs across a number of therapeutic areas including respiratory disease, bacterial infections, overactive bladder and gastrointestinal disorders. For more information on any Amex-listed company, please visit http://www.amex.com/. The American Stock Exchange(R) (Amex(R)) is the only primary exchange that offers trading across a full range of equities, options and exchange traded funds (ETFs), including structured products and HOLDRS(SM). In addition to its role as a national equities market, the Amex is the pioneer of the ETF, responsible for bringing the first domestic product to market in 1993. Leading the industry in ETF listings, the Amex lists 151 ETFs. The Amex is also one of the largest options exchanges in the U.S., trading options on broad-based and sector indexes as well as domestic and foreign stocks. For more information, please visit http://www.amex.com/. DATASOURCE: American Stock Exchange CONTACT: Kelsey Hubbard of American Stock Exchange, +1-212-306-1640, Web site: http://www.amex.com/

Copyright

1 Year Spdr Msci Europe Materia... Chart

1 Year Spdr Msci Europe Materia... Chart

1 Month Spdr Msci Europe Materia... Chart

1 Month Spdr Msci Europe Materia... Chart

Your Recent History

Delayed Upgrade Clock